Biologics represent over 50% of all new medicines, and their share continues to grow, solidifying their central role in the future of therapeutics. Yet developing and manufacturing these complex drugs remains a major challenge with costs at least 10 times higher than traditional pharmaceuticals and an average time-to-market stretching from 10 to 15 years. Additionally, current biopharmaceutical manufacturing is one of the most resource-intensive industries, with a process mass intensity (PMI) 10 times higher than that of small-molecule pharmaceuticals.

We Created Auga™ to Elevate Your Workflows

At ArgusEye, we help you tackle the challenges of bioprocessing with our advanced biosensing technology designed as a next-generation Process Analytical Technology (PAT) solution, delivering rapid in-process data every second. Our cutting-edge LSPR (Localized Surface Plasmon Resonance) sensor platform enables continuous monitoring of a wide range of targets, providing real-time tracking of critical quality attributes (CQAs) and critical process parameters (CPPs) from day one. This empowers the industry to adopt faster, more streamlined, and automated processes in line with modern PAT frameworks, improving quality control, reducing development time and cost, and minimizing environmental impact.

Embedded within Auga™, our modular biosensing platform, this proprietary LSPR sensor technology enables seamless integration of high-performance sensing systems across the bioprocess stream. By incorporating Auga™ into your workflows, you unlock immediate and measurable impact—enhancing operational performance while contributing to a more sustainable and accessible future for biopharmaceuticals.

Transformative Impact on Bioprocess Workflows with Unique PAT

Save Time and Cut Costs—Significantly

With Auga™, biopharma companies can realize significant savings and shorten timelines at every stage of development. Real-time measurements reduce the need for manual sampling and laboratory testing, which streamlines operations, minimizes resource use, and eliminates delays caused by batch-based analytics.

From consumables and resins to energy and labor, you gain efficiency at every stage. This leads to faster process development cycles and shorter lead times—saving days on each experiment and months across entire development programs. As a result, you could bring therapies to market 1-2 years earlier, unlocking significant additional revenue. In a highly competitive landscape, that kind of advantage can be decisive.

Enable Automation and Bioprocess Intensification

Real-time, in-line monitoring opens the door to true process automation. With ArgusEye’s unique technology, hands-on time is dramatically reduced, and data reliability is enhanced by eliminating the need for manual off-line testing. This not only allows for optimization of labor hours but also increases consistency and reduces variability—key factors in achieving high-quality, reproducible outcomes.

With every sample analyzed instantly and automatically, you can streamline workflows, reduce risk, and create a scalable foundation for digital transformation. Your teams can shift focus from operational bottlenecks to strategic innovation.

A Critical Enabler for Continuous Bioprocessing

With continuous, high-frequency insights into CQAs and CPPs, our solution supports a fundamental shift toward continuous processing. Rather than relying on delayed or average measurements, you gain real-time visibility in downstream and upstream processes, enabling early detection of deviations. This leads to tighter process control, reduced variability, and greater overall stability in your workflows.

With significant process intensification enabled with our technology, companies can achieve a 40–60% reduction in OPEX in biopharmaceutical manufacturing. When applied in integrated continuous processing, it functions as a key enabler for significant reduction in capital expenditures through the use of connected smaller-scale vessels and equipment, along with a reduced need for off-line laboratory analysis leading to up 80% CAPEX savings.

Transformative Impact on Bioprocess Workflows with Unique PAT

By adopting ArgusEye’s advanced sensing technology in your processes, you’re not just transforming your internal operations—you are contributing to a broader impact that benefits patients worldwide and the planet.

A Critical Enabler for Continuous Bioprocessing

More automation means fewer errors and less extra work. More efficient processes lead to lower emissions and reduced waste. Together, these improvements support your sustainability goals while aligning with regulatory and investor expectations.

Auga™ helps reduce the environmental impact of your operations by enhancing material and energy efficiency. By minimizing waste, cutting down on excess reagents and consumables, and enabling shorter, more sustainable pharmaceutical production cycles, Auga™ supports a cleaner, more efficient manufacturing model. Its continuous manufacturing capability contributes to a 65% reduction in Process Mass Intensity (PMI), significantly lowering resource consumption.

Reinforcing this impact, a life cycle assessment (LCA) conducted by ClimatePoint shows that integrating ArgusEye’s sensor systems in monoclonal antibody (mAb) production can reduce emissions by approximately 96% compared to traditional methods like HPLC (excluding emissions from the overall medicine production process). The study also found a 95% reduction in the use of non-renewable energy per gram of mAbs when using ArgusEye’s technology.

Accelerate Access to Life-Changing Therapies

Time saved in development isn’t just a cost-saving metric—it’s a human one. Every month shaved off your development timeline is a month sooner that a new therapy can reach patients.

By enabling faster, more predictable bioprocessing, we help you ensure that critical biologics get to those in need more quickly. As the demand for complex biologics grows, your ability to deliver faster can make a measurable difference in healthcare outcomes.

Biopharma is Evolving–Be Ahead of the Curve

At ArgusEye we are passionate about helping you lead the future of bioprocessing–making it faster, smarter, and more sustainable. Partner with us to unlock new levels of efficiency, quality, and control across your processes.

Do you have questions or are you ready to explore what is possible? We’re here to help.

Contact us today to start the conversation or request a personalized demo.